India’s Pharmaceutical Logistics: A Global Backbone for Healthcare

India’s pharmaceutical logistics sector plays a critical role in global healthcare, supporting the seamless delivery of essential medicines, vaccines, and therapeutic solutions. As the largest vaccine producer worldwide, India accounts for almost 2/3 of global vaccine production! These vaccines are essential to global immunization efforts, and India’s supply chain ensures their distribution across more than 150 countries.

In addition to vaccines, India is a leading supplier of generic medicines, holding a 20% share of the global market by volume.

With over 10,500 manufacturing facilities and the highest number of US-FDA-compliant plants outside the United States, India maintains a robust logistics network capable of efficiently distributing high-quality medicines at competitive prices.

This network has been instrumental in global health, particularly in providing affordable HIV treatments and addressing drug shortages in regions like Africa, the U.S., and the UK.

The Indian government’s initiatives, such as the creation of bulk drug parks in Gujarat, Himachal Pradesh, and Andhra Pradesh, are designed to enhance drug security and improve the production of active pharmaceutical ingredients (APIs).

These parks will contribute to a more consistent supply of bulk drugs and strengthen the country’s pharmaceutical infrastructure.

Overall, India’s pharmaceutical logistics industry remains a vital component of the global healthcare system, ensuring the reliable supply of life-saving medicines and vaccines while supporting the country’s position as the “pharmacy of the world.”